This press release is intended for business journalists and analysts/investors. Please note that this release may not have been issued in every market in which GSK operates.
GSK announces Q2 results for 2010
Q2 EPS before major restructuring* 2.6p (29.3p excluding pre-announced legal charge)
Download GSK Q2 results 2010 as a PDF
For further details, videos and the analyst webcast, visit the Investors section of GSK.com.
GSK multimedia press room
Corporate media center
Corporate investors site
Save money on prescription medicines
Updated 21 July 2010
© 2001 - 2007 GlaxoSmithKline - All rights reserved

